Ketamine and the Neurobiology of Depression: Toward Next-generation Rapid-acting Antidepressant Treatments
John Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry, of Neuroscience, and of Psychology; and Irina Esterlis, PhD, associate professor of psychiatry, are first and senior authors, respectively, of a review published in Proceedings of the National Academy of Sciences Perspective that considers what scientists have learned from studies of ketamine and to suggest future directions for the optimization of rapid-acting antidepressant treatment.Source: Proceedings of the National Academy of Sciences Perspective
Electronic Nicotine Delivery Systems and E-Liquid Modifications to Vape Cannabis Depicted in Online Videos
Rachel Ouellette, PhD; Sophia Selino, BA; and Grace Kong, PhD, are co-authors of a paper in JAMA Network Open that analyzed YouTube videos for use, modification, and marketing of electronic nicotine delivery systems to vape cannabis.Source: JAMA Network Open
FDA Makes a Move to Ban Menthol and Flavored Cigarettes
Public health experts have long urged the government to take action against menthol-flavored cigarettes, and the Food and Drug Administration is finally stepping up. “Eliminating menthol in cigarettes would reduce youth from starting to smoke and similarly, eliminating all flavors in e-cigarettes would drastically reduce youths from starting to use tobacco products,” says YSPH's Jody Sindelar.Source: The Messenger
There’s a Pill That Helps People Quit Smoking. Why Isn’t It Sold in the U.S.?
Lisa Fucito, PhD, associate professor of psychiatry, spoke to Slate Magazine about a new review on pharmacological and e-cigarette interventions for smoking cessation and the fact that one of the effective interventions, cytisine, is not available in the United States.Source: Slate
$20M Federal Grant Renewed for Yale Tobacco Center of Regulatory Science
The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) have renewed a $20 million grant for the Yale Tobacco Center of Regulatory Science (TCORS). The Yale center is led by co-directors Suchitra Krishnan-Sarin, PhD, Albert E. Kent Professor of Psychiatry; and Stephanie O’Malley, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry.
Investigators Launch Study Aimed at Accelerating Understanding of Bipolar Disorder
A multidisciplinary team of researchers based at Yale will launch a series of studies aimed at accelerating understanding of bipolar disorder and generating new and more effective treatments. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience and Professor of Psychiatry, and in the Child Study Center and of Radiology and Biomedical Imaging, will lead the research team.
Picciotto to Direct Interdepartmental Neuroscience Program
Marina Picciotto, PhD, Charles B. G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, has been appointed director of the Interdepartmental Neuroscience Program, the largest doctoral program in the biological and biomedical sciences at Yale.
Can a Person's Sex and Gender Affect Tobacco Use?
The short answer .... yes. A viewpoint by Women's Health Research at Yale, published in JAMA, explains the differences in tobacco use and how public health leaders can use the information to improve tobacco policies and regulations.Source: Youtube | Women's Health Research at Yale
What to Know About E-cigarettes: A Q&A With Stephen Baldassarri
Stephen Baldassarri, MD, MHS, assistant professor of medicine (pulmonary, critical care and sleep medicine), discusses the basics of e-cigarettes, how e-cigarettes compare to conventional cigarettes, and the future of vaping and smoking.
Delta-9-Tetrahydrocannabinol Modulates Pain Sensitivity Among People Receiving Opioid Agonist Therapy
Joao De Aquino, MD, assistant professor of psychiatry, and Mehmet Sofuoglu, MD, PhD, professor of psychiatry, are first and senior authors, respectively, of a study in Addiction Biology that studies the acute effects of the delta-9-tetrahydrocannabinol among people receiving methadone therapy for opioid use disorder.Source: Addiction Biology
Haeny Receives Early Career Investigator Award from MOBC
Angela M. Haeny, PhD, assistant professor in the Department of Psychiatry and director of the Racial Equity & Addiction Lab, was the recipient of the 2023 Early Career Investigator Award from the Translational Mechanisms of Behavior Change (MOBC) Satellite Meeting at the Research Society on Alcohol (RSA).
Considerations of Sex and Gender in FDA Tobacco Regulation
Danielle R. Davis, PhD, assistant professor of psychiatry; Suchitra Krishnan-Sarin, PhD, Albert E. Kent Professor of Psychiatry; and Carolyn M. Mazure, PhD, Norma Weinberg Spungen and Joan Lebson Bildner Professor in Women's Health Research and Professor of Psychiatry and of Psychology, and director, Women's Health Research at Yale, provide examples of proposed regulatory changes by the FDA that could benefit from a greater focus on women and the influence of sex and gender on tobacco use.Source: JAMA
Yale Study: Transdiagnostic Connectome-Based Prediction of Craving
Kathleen Garrison, PhD; Rajita Sinha, PhD; Marc Potenza, MD, PhD; and Dustin Scheinost, PhD, are co-authors of a paper in American Journal of Psychiatry that uses connectome-based predictive modeling to predict self-reported craving from brain functional connectivity data.Source: American Journal of Psychiatry
In conversation with Nii Addy
In honor of its 25th anniversary, Nature Neuroscience spoke to Dr. Nii Addy, the Albert E. Kent Associate Professor of Psychiatry and Associate Professor of Cellular and Molecular Physiology, and the inaugural Director of Scientist Diversity and Inclusion at Yale School of Medicine.Source: Nature Neuroscience
Addy Featured on PBS Series 'Healthy Minds'
Nii Addy, PhD, Albert E. Kent Associate Professor of Psychiatry, Associate Professor of Cellular and Molecular Physiology, is featured on the eighth season of the PBS television series Healthy Minds with Dr. Jeffrey Borenstein, which debuts nationally May 1.
Investigating the associations of acute psychedelic experiences and changes in racial trauma symptoms, psychological flexibility, and substance use among People with Racial and Ethnic Minoritized Identities in the United States and Canada
Angela Haeny, PhD, assistant professor of psychiatry, and a team of Yale Psychiatry researchers investigated the impact of psychedelics on substance use outcomes among people of color.Source: Journal of Substance Use and Addiction Treatment